Avivagen, Inc.Avivagen, Inc.Avivagen, Inc.

Avivagen, Inc.

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
Revenue estimate
Market capitalization
‪282.60 K‬USD
‪76.97 M‬
Beta (1Y)
6.94

About AVIVAGEN INC

CEO
G. F. Kym Anthony
Headquarters
Ottawa
Founded
2005
FIGI
BBG000TCDKL9
Avivagen, Inc. engages in the development and commercialization of products for livestock. Its products include OxC-beta Livestock, Vivamune Vital Health Chews and Oximunol Chewable Tablets. The company was founded by Janusz Daroszewsk and Graham W. Burton on August 4, 2005 and is headquartered in Ottawa, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VIVXF is 0.0064 USD — it has increased by 72.97% in the past 24 hours. Watch Avivagen, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Avivagen, Inc. stocks are traded under the ticker VIVXF.
Avivagen, Inc. is going to release the next earnings report on Jun 4, 2024. Keep track of upcoming events with our Earnings Calendar.
VIVXF stock is 42.19% volatile and has beta coefficient of 6.94. Track Avivagen, Inc. stock price on the chart and check out the list of the most volatile stocks — is Avivagen, Inc. there?
VIVXF earnings for the last quarter are −0.02 USD per share, whereas the estimation was −0.02 USD resulting in a −20.00% surprise. The estimated earnings for the next quarter are −0.01 USD per share. See more details about Avivagen, Inc. earnings.
Avivagen, Inc. revenue for the last quarter amounts to ‪37.97 K‬ USD despite the estimated figure of ‪156.22 K‬ USD. In the next quarter revenue is expected to reach ‪128.42 K‬ USD.
Yes, you can track Avivagen, Inc. financials in yearly and quarterly reports right on TradingView.
Today Avivagen, Inc. has the market capitalization of ‪284.01 K‬, it has decreased by 1.02% over the last week.
No, VIVXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VIVXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Avivagen, Inc. stock right from TradingView charts — choose your broker and connect to your account.
VIVXF reached its all-time high on Oct 19, 2016 with the price of 1.5000 USD, and its all-time low was 0.0004 USD and was reached on Dec 21, 2023. View more price dynamics on VIVXF chart.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Avivagen, Inc. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Avivagen, Inc. stock shows the sell signal. See more of Avivagen, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.